300 mg/day of standardized extract (≈50% bacosides), with food, for ≥8–12 weeks. The effects are chronic, not acute.
Meta-analysis of 9 RCTs: significant improvement in verbal memory, sustained attention and processing speed at 12 weeks, greater in people over 55.
View the study (meta-analysis) →300 mg/day of standardized extract for 12 weeks: reduction in anxiety scores (HAM-A and STAI), with a dual sedative-cognitive profile. Slower than Silexan but with added cognitive benefit.
View the study (RCT) →Bacopa reduces reactivity to acute stress and maintains cognitive performance in high-demand situations.
View the study (RCT) →⏱ 2 min read
Bacopa monnieri, also known as brahmi in the Ayurvedic tradition, is an aquatic plant that grows in wetlands of India and other tropical regions and has been used for centuries as a brain tonic in traditional medicine; in recent decades it has established itself as one of the few cognitive supplements with serious clinical evidence from randomized trials, especially for improving learning memory with prolonged use.
The main active compounds are bacosides, a family of triterpenoid saponins that appear to act on multiple systems: they facilitate cholinergic synaptic transmission, modulate the activity of the serotonergic 5-HT1A receptor, offer antioxidant protection to neurons, and increase the activity of several brain enzymes involved in synaptic plasticity; products standardized to 20-55 percent bacosides are those used in clinical trials.
The indication with the best evidence is improvement of learning memory with prolonged use: several meta-analyses of randomized trials have shown significant improvements in free recall tests, visual memory, and learning speed with doses of 300-450 milligrams daily of standardized extract for at least 12 weeks, ideally 24 weeks to appreciate the full effect in healthy people.
Unlike caffeine or fast-acting nootropics, Bacopa does not produce a noticeable acute effect in the first week; the effect builds up progressively over 8-12 weeks and is maintained as long as supplementation lasts, which requires initial patience but offers a more sustained profile of cognitive improvement without habituation.
In subclinical anxiety and mild generalized anxiety disorder, several trials have shown significant improvements on standardized scales (Hamilton, BAI) with doses of 300-600 milligrams daily for 8-12 weeks; the effect is modest but subjectively noticeable and is accompanied by improvements in sleep quality and in the general sense of calm, without daytime sedation.
The most plausible mechanism combines modulation of the 5-HT1A receptor (with an effect similar to that of buspirone but milder), reduction of perceived cortisol in stressful situations, and a neurogenic effect on the hippocampus, a brain region whose plasticity is reduced in chronic anxious and depressive conditions.
In childhood ADHD, several studies have shown modest improvements in attention and impulsivity with standardized extracts over several weeks; in mild cognitive impairment and in normal aging with subjective memory complaints, several trials suggest benefits when combined with lifestyle changes and other cognitive interventions; in epilepsy and migraine there are promising preliminary data that are not yet consolidated.
The doses studied range from 300 to 600 milligrams daily of extract standardized to 50-55 percent bacosides, ideally with a fatty meal to improve absorption (bacosides are lipophilic); the cognitive effect requires sustained use for at least 8-12 weeks to appear, a characteristic that clearly distinguishes Bacopa from fast-acting stimulants.
Generally well tolerated; the most common adverse effects are mild digestive discomfort (nausea, cramps, diarrhea), which eases when it is taken with food; some people report fatigue or dry mouth at the start; people who take serotonergic antidepressants, anticonvulsants, or thyroid medication should check first about theoretical interactions that are not fully characterized in the clinical literature; it is best avoided during pregnancy and breastfeeding because of limited data.
Information, not medical advice. Scientific evidence reflects the quality of the studies.